FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Transderm Scop (scopolamine) by Baxter Healthcare Corporation, updating the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness
• Postoperative Nausea and Vomiting

Drugs mentioned

• TRANSDERM SCOP (SCOPOLAMINE)

Snippet

SUPPL AP for TRANSDERM SCOP (SCOPOLAMINE)